Trending...
- LIGUORI ACADEMY- KRAVINSKY LITERACY PROGRAM FOUNDED BY PHILANTHROPIST, ZELL KRAVINSKY
- SIGLENT Technologies Expands the Addressable Frequency Range of its RF Instruments to Best Support Microwave Range
- KiwiQA chosen as the preferred testing vendor by Stone & Chalk, leading Australia-based innovation Start-up & scaleup hub
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming October 31, 2022 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Azure Power Global Limited ("Azure" or the "Company") (NYSE: AZRE) securities between June 15, 2021 and August 26, 2022, inclusive (the "Class Period").
Investors suffering losses on their Azure investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.
On August 29, 2022, Azure announced the resignation of its CEO, less than two months after his appointment. The Company also disclosed that it had "received a whistleblower complaint in May 2022 alleging potential procedural irregularities and misconduct by certain employees at a plant belonging to one of its subsidiaries." During the Company's review of these allegations, Azure "discovered deviations from safety and quality norms" and "also identified evidence of manipulation of project data and information by certain employees."
More on The PennZone
On this news, the Company's stock fell $4.61, or 44%, to close at $5.85 per share on August 29, 2022, on unusually heavy trading volume.
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that there were procedural irregularities, including deviations from safety and quality standards, at one of Azure's plants; (2) that certain project data was manipulated; (3) that, as a result of the foregoing, the Company's internal controls and procedures were not effective; (4) that Azure had received a credible whistleblower report alleging such misconduct; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you purchased or otherwise acquired Azure securities during the Class Period, you may move the Court no later than October 31, 2022 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.
More on The PennZone
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
Investors suffering losses on their Azure investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.
On August 29, 2022, Azure announced the resignation of its CEO, less than two months after his appointment. The Company also disclosed that it had "received a whistleblower complaint in May 2022 alleging potential procedural irregularities and misconduct by certain employees at a plant belonging to one of its subsidiaries." During the Company's review of these allegations, Azure "discovered deviations from safety and quality norms" and "also identified evidence of manipulation of project data and information by certain employees."
More on The PennZone
- Statement Pursuant to Section 19(a) of the Investment Company Act of 1940: DEX
- Pennsylvania: Gov. Wolf Signs Legislation Extending Authority of State Horse Racing Commission
- Gov. Wolf: More Than 1.7 Million Pennsylvanians Eligible for Relief on Student Loans
- Ironside Human Resources Announces Office Expansion Due to Rapid Growth
- Gov. Wolf Reminds Pennsylvanians to Explore Affordable Health Care Options through Pennie Ahead of Open Enrollment Period
On this news, the Company's stock fell $4.61, or 44%, to close at $5.85 per share on August 29, 2022, on unusually heavy trading volume.
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that there were procedural irregularities, including deviations from safety and quality standards, at one of Azure's plants; (2) that certain project data was manipulated; (3) that, as a result of the foregoing, the Company's internal controls and procedures were not effective; (4) that Azure had received a credible whistleblower report alleging such misconduct; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you purchased or otherwise acquired Azure securities during the Class Period, you may move the Court no later than October 31, 2022 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.
More on The PennZone
- Aspirant Announces New Organizational Effectiveness Principal
- Evangeline M. Mitchell Named as the Recipient of the Bar Association of DC's 150th Anniversary Presidential Award
- Qurate Retail Group Names Scott Barnhart Chief Operating Officer
- Corrupt Nypd Official Captured On Camera
- Grammy® Nominated Duo Helen Bruner & Terry Jones New Single & Visuals For "At Dinner 32"
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
Filed Under: Business
0 Comments
Latest on The PennZone
- Gov. Wolf's $25 Million State Child Care Tax Credit Will Support 221,000 Working Families in Pennsylvania
- Lincoln Financial Group to Report Third Quarter Earnings
- The Democracy Group launches fellowship for aspiring Gen Z podcasters
- Sydney Brachytherapy Group is the first private non-melanoma skin cancer clinic in Sydney to offer OncoBeta's Rhenium-SCT
- UnityLab Secures $4.5 Million Series A Funding to Accelerate Growth, Add Jobs and Expand Manufacturing Operations in Dushore, Pennsylvania
- PermaTherm Announces Panels Delivered Quickly Program
- ASI Hosts 24th Annual iNNOVATIONS Conference and Announces Award Winners
- Myonex Launches CTRx Europe, Central Pharmacy Network
- MolecuLight Point-of-Care Wound Imaging Devices Awarded Group Purchasing Agreement with AllSpire Health GPO
- Cantaloupe, Inc. to Delay Form 10-K Filing for Fiscal Year 2022
- Hundreds Walk For Recovery, Jobs A Solution
- The World's First Stuttering Mentalist - Johnathan Smith Is A Story Of Determination And Hard Work
- Pennsylvania: Gov. Wolf Announces Deployment of PA-Task Force 1 to Support Hurricane Ian Response
- InHome Therapy Announces $22 Million Investment Led by TT Capital Partners to Fuel Growth and Expansion
- BEAR Technologies Successfully Completes 2022 SOC 2 Type II Audit
- Exterro Launches FTK® Suite 7.6, Introducing Mobile Parsing, Automation Capabilities, And Industry-First Remote Endpoint Triage
- Kitchen Magic Adopts Zero-Waste-to-Landfill Initiative
- Pennsylvania: Gov. Wolf, Lt. Gov. Fetterman: Time is Running Out for People Interested in Quick Pardons through PA Marijuana Pardon Project
- AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2022 Earnings Release
- Re-Introducing Gigahurtz, DJ and Producer